Information processing, neuropsychological, and neurobiological processes in pediatric obsessive-compulsive disorder

Completed

• Conditions: Obsessive-Compulsive Disorder (OCD); Mental and Behavioural Disorders; Obsessive Compulsive Disorder (OCD)

• Registration Number: ISRCTN07851536
• Lead Sponsor: Academic Medical Center (AMC) (The Netherlands)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2006-09-26
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 45

Inclusion Criteria

1. Children and adolescents eight to 18 years
2. Primary diagnosis: Obsessive Compulsive Disorder (OCD)
3. OCD symptoms for more than six months
4. Children's Yale-Brown Obsessive Compulsive Scale (CY-BOCS) total score more than 16
5. IQ (Intelligence Quotient) more than 80
6. Informed consent of parents and child

Exclusion Criteria

Use of the following medication:
1. Selective Serotonin Reuptake Inhibitor (SSRI)
2. Tricyclic Antidepressant (TCA)
3. Anti-psychotic medication

For neurobiological measures (functional Magnetic Resonance Imaging [fMRI]):
1. Claustrophobia
2. Metal on body

Study & Design

• Study Type: Interventional
• Study Design: Not specified